Ictero Medical plans first human studies after raising $6M from MedTex, S3
A Houston-based medical device company plans to pursue its first human studies after an injection of financing.
In late April, Ictero Medical Inc. announced raising $6 million in Series A financing led by Connecticut-based MedTex Ventures, Austin-based S3 Ventures and an undisclosed strategic investor.
Ictero is developing a device for high-risk patients with gallbladder disease. The company has shown in animal models that the device is able to ablate the functions of the gallbladder with extreme…
